Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, CorMedix Inc’s stock clocked out at $12.16, down -1.78% from its previous closing price of $12.38. In other words, the price has decreased by -$1.78 from its previous closing price. On the day, 1.61 million shares were traded. CRMD stock price reached its highest trading level at $12.67 during the session, while it also had its lowest trading level at $12.02.
Ratios:
To gain a deeper understanding of CRMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.96. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on January 13, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On August 26, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $13.
On August 10, 2023, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $6.RBC Capital Mkts initiated its Outperform rating on August 10, 2023, with a $6 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 31 ’24 when Mistry Erin bought 1,500 shares for $9.99 per share. The transaction valued at 14,985 led to the insider holds 52,011 shares of the business.
Hurlburt Elizabeth sold 140,027 shares of CRMD for $1,565,670 on Nov 14 ’24. The EVP now owns 45,397 shares after completing the transaction at $11.18 per share. On Nov 14 ’24, another insider, Hurlburt Elizabeth, who serves as the Officer of the company, bought 140,027 shares for $11.12 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRMD now has a Market Capitalization of 737834752 and an Enterprise Value of 692361728. For the stock, the TTM Price-to-Sale (P/S) ratio is 60.18 while its Price-to-Book (P/B) ratio in mrq is 11.99. Its current Enterprise Value per Revenue stands at 56.463 whereas that against EBITDA is -13.638.
Stock Price History:
The Beta on a monthly basis for CRMD is 1.58, which has changed by 3.122034 over the last 52 weeks, in comparison to a change of 0.25219524 over the same period for the S&P500. Over the past 52 weeks, CRMD has reached a high of $13.85, while it has fallen to a 52-week low of $2.89. The 50-Day Moving Average of the stock is 21.35%, while the 200-Day Moving Average is calculated to be 66.68%.
Shares Statistics:
It appears that CRMD traded 1.25M shares on average per day over the past three months and 1290990 shares per day over the past ten days. A total of 60.68M shares are outstanding, with a floating share count of 59.25M. Insiders hold about 2.35% of the company’s shares, while institutions hold 31.49% stake in the company. Shares short for CRMD as of 1736899200 were 7083149 with a Short Ratio of 5.68, compared to 1734048000 on 6728207. Therefore, it implies a Short% of Shares Outstanding of 7083149 and a Short% of Float of 11.690000000000001.
